The pilot project is part of Project Mosaic, an effort to create better disease models of sporadic ALS and spur development of precision drugs.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

Researchers at the Gray Faculty of Medical and Health Sciences at Tel Aviv University have developed a model that accurately replicates an extremely rare and sometimes fatal genetic disorder caused by ...

CAMBRIDGE, England & EDINBURGH, Scotland & GRASSE, France--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today ...

MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the ...

Despite swimming in different worlds, fish and humans are biologically much closer than one might think. Capitalizing on this ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new therapies for global markets Read more at straitstimes.com. Read more at ...

Scientists invented a pocket-sized model of the most common form of amyotrophic lateral sclerosis (ALS). The "disease-on-a-chip," made using stem cells, could pave the way for new treatments for the ...

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...

New research reveals that lithium helps protect against neurodegeneration and Alzheimer's disease by preventing toxic amyloid ...

Firefly collaborates with NVIDIA to enhance its BNA™ platform and aims to create a foundation model of the human brain. Firefly Neuroscience, Inc. has announced its acceptance into the NVIDIA Connect ...